Printer Friendly

Browse Drug approval topic

 

Articles

1-300 out of 500 article(s) nextnext page
Title Author Type Date Words
United States : FDA approves NIPRO DIAGNOSTICS products. Aug 26, 2014 262
GSK receives FDA approval of an additional Promacta (eltrombopag) indication for use in patients with severe aplastic anaemia (SAA) who have had an insufficient response to immunosuppressive therapy (IST). Aug 26, 2014 2472
Tocagen Expands Clinical Development Team;. Aug 26, 2014 741
United States : FDA approval for BOEHRINGER drug. Aug 23, 2014 117
ViiV Healthcare receives FDA approval for Triumeq (abacavir, dolutegravir and lamivudine), a new single-pill regimen for the treatment of HIV-1 infection. Aug 22, 2014 2179
Actavis Confirms Generic Neupro Patent Challenge. Aug 22, 2014 953
Mylan Launches First Generic Klor-Con Extended-Release Tablets. Aug 22, 2014 374
Colgate Total: The Only Absolutely Safe Toothpaste Approved by FDA That Treats Gingivitis and Plaque and Doesn't Cause Cancer. Aug 22, 2014 350
United Kingdom : GSK receives FDA approval for Arnuity Ellipta (fluticasone furoate) in the USA for the treatment of asthma. Aug 22, 2014 304
United States : BMS, CELGENE announce plans to establish phase I clinical trial program. Aug 22, 2014 313
ViiV Healthcare receives FDA approval for Triumeq (abacavir, dolutegravir and lamivudine), a new single-pill regimen for the treatment of HIV-1 infection. Aug 22, 2014 2172
United States : Amerigen Pharmaceuticals Ltd. announces that its Chinese subsidiary, Suzhou Amerigen Pharmaceuticals Co. Ltd., has received Chinese FDA (CFDA) approval and has subsequently launched it. Aug 21, 2014 248
GSK receives FDA approval for Arnuity(TM) Ellipta (fluticasone furoate) in the US for the treatment of asthma. Aug 20, 2014 924
United States : FDA approves new drug to treat a form of Gaucher disease. Aug 20, 2014 454
Drug Approvals, Clinical Trial Result, and Philanthropic Activity - Research Reports on Johnson & Johnson, Biogen, Amgen, Medtronic and Merck. Aug 20, 2014 1662
Amerigen Pharmaceuticals Ltd. announces that its Chinese subsidiary, Suzhou Amerigen Pharmaceuticals Co. Ltd., has received Chinese FDA (CFDA) approval and has subsequently launched its generic Mecobalamin 0.5 mg Tablets into the China domestic market. Aug 20, 2014 449
Mylan Launches Generic Precedex(TM) Injection - Another Key Product Approval. Aug 19, 2014 624
Xeljanz's Label Extension to Include Reduction of Radiographic Progression of Structural Joint Damage in RA Has Positively Impacted U.S. Rheumatologists' Perceptions of This Agent. Aug 18, 2014 690
Globavir Seeking Approval and Launch of Novel Ebola Treatment Before Year End. Aug 18, 2014 991
United States : B BRAUN's Nutrilipid 20% gets approval from US FDA. Aug 18, 2014 220
Cannabis-based drug is approved for use INWALES. Aug 16, 2014 613
Drug Approvals & Updates, Licensing Agreements, and Upcoming Conferences - Research Reports on Tekmira, MannKind, Eli Lilly, GSK and Cigna. Aug 14, 2014 1627
United States : FDA approves new type of sleep drug, Belsomra. Aug 14, 2014 456
FDA Advisory Committee Recommends Approval of Tiotropium Respimat for the Maintenance Treatment of COPD. Aug 14, 2014 1485
B. Braun Receives FDA Approval for Nutrilipid 20%. Aug 13, 2014 431
AIDS activist has a new fight -- defending FDA. Perrone, Matthew Aug 12, 2014 827
Japan : FDA Approves VELCADE (bortezomib) Retreatment in Patients with Multiple Myeloma. Aug 12, 2014 440
Mylan Launches Generic Xeloda Tablets. Aug 11, 2014 581
First Varicose Vein Patient Treated with FDA-Approved Varithena (polidocanol injectable foam) 1%. Aug 11, 2014 1038
United States : U.S. FDA Approves INVOKAMET (canagliflozin/metformin HCl) for the Treatment of Adults with Type 2 Diabetes. Aug 9, 2014 440
United States : Medtronic Receives FDA Approval for Attain Performa Quadripolar Lead and Viva Quad CRT-Ds in United States. Aug 8, 2014 415
United States : FDA approves Orbactiv to treat skin infections. Aug 7, 2014 376
NextSource Biotechnology Gains FDA Approval for Use of Tradename Gleostine(TM) (Lomustine), an Anti-Cancer Chemotherapy Agent. Aug 7, 2014 439
Canada : Aeterna Zentaris and ASCEND Therapeutics Sign Co-Promotion Agreement for U.S. Market. Aug 6, 2014 375
Perlstein Lab Raises $2 Million For Orphan Drug Discovery. Aug 5, 2014 579
Aeterna Zentaris and ASCEND Therapeutics Sign Co-Promotion Agreement for U.S. Market. Aug 5, 2014 1147
United States : FDA Approves Baxter's FLEXBUMIN 5%, First and Only 5% Human Albumin Solution in a Flexible Container. Aug 5, 2014 296
United Kingdom : FDA Advisory Committee Panel Provides Favorable Recommendation on Baxter's HyQvia for Primary Immunodeficiency. Aug 2, 2014 277
United States : FDA approves Jardiance to treat type 2 diabetes. Aug 2, 2014 429
United States : FDA expands approval of drug to treat Pompe disease to patients of all ages; removes risk mitigation strategy requirements. Aug 2, 2014 385
FDA Approves Boehringer Ingelheim's Striverdi Respimat (olodaterol) Inhalation Spray for Maintenance Treatment of COPD. Aug 1, 2014 1508
60+ Healthcare Professionals Sign an Open Letter Urging the FDA to Approve First-Ever Drug to Treat Women's Most Common Form of Sexual Dysfunction, notes Even the Score. Aug 1, 2014 893
United States : FDA approves Striverdi Respimat to treat chronic obstructive pulmonary disease. Aug 1, 2014 411
FDA approves Jardiance (empagliflozin) tablets for adults with type 2 diabetes. Aug 1, 2014 2196
Germany : Aflibercept Solution for Injection into the Eye Receives FDA Approval for the Treatment of Diabetic Macular Edema (DME). Jul 31, 2014 466
Ampio Pharmaceuticals announces the FDA has issued a written response and accepted the Ampio plan for beginning production of Ampion(TM) in the new facility. Jul 30, 2014 559
United States : IMBRUVICA (ibrutinib) Receives Regular Approval by U.S. FDA in Chronic Lymphocytic Leukemia (CLL) and CLL patients with del 17p. Jul 30, 2014 408
United States : FDA expands approved use of Imbruvica for chronic lymphocytic leukemia. Jul 30, 2014 439
FDA Performs Inspection of Impax's Taiwan Facility. Jul 29, 2014 1244
U.S. FDA Grants Regular (Full) Approval for IMBRUVICA for Two Indications. Jul 28, 2014 2739
IMBRUVICA (ibrutinib) Receives Regular Approval by U.S. FDA in Chronic Lymphocytic Leukemia (CLL) and CLL patients with del 17p. Jul 28, 2014 2907
Germany : EUROPEAN COMMISSION approves the new RENEWABLE ENERGY ACT. Jul 25, 2014 375
United Kingdom,United States : FDA approves Flonase allergy relief for sale over-the-counter in the United States. Jul 25, 2014 432
Perrigo Confirms AB Therapeutic Equivalent Rating From The FDA For Its Testosterone Gel 1.0%. Jul 24, 2014 744
FDA Approves Flonase Allergy Relief For Sale Over-The-Counter In The United States. Jul 24, 2014 1859
United States : FDA approves new extended-release oxycodone with abuse-deterrent properties. Jul 24, 2014 451
United States : FDA approves Zydelig for three types of blood cancers. Jul 24, 2014 440
AcelRx Pharmaceuticals Confirms July 27, 2014 PDUFA Date for Zalviso. Jul 24, 2014 495
The Leukemia & Lymphoma Society Applauds FDA's Approval of Idelalisib To Treat Three Types of Blood Cancers. Jul 23, 2014 505
A collection of approx..1100 FDA approved drugs in pre-dissolved 100ul of DMSO solution for high throughput screening (HTS) and high content screening (HCS). It should be stored in screw cap tubes in. Jul 22, 2014 138
Dipexium Pharmaceuticals Initiates Second of Two Pivotal Phase 3 Clinical Trials of Locilex in Patients with Mild Infections of Diabetic Foot Ulcers. Jul 21, 2014 984
Bioniche Announces Intention to File for Marketing Approval of MCNA in the United States. Jul 18, 2014 639
United States : FDA approves new product to treat rare genetic disease. Jul 18, 2014 357
United States : US FDA grants approval to SALIX and PHARMING for Ruconest. Jul 18, 2014 132
Agile Therapeutics Announces Allowance of Additional Patent Claims for Skinfusion. Jul 17, 2014 811
IBA Receives FDA Approval of its New Compact Gantry Clearing the Way for ProteusONE. Jul 16, 2014 284
FDA Approves the Freedom Portable Driver That Powers The SynCardia Total Artificial Heart. Jul 16, 2014 998
IBA Receives FDA Approval of its New Compact Gantry Clearing the Way for ProteusONE. Jul 16, 2014 289
United States : Janssen Pharmaceuticals Seeks Expanded Label for Once-Monthly INVEGA SUSTENNA (paliperidone palmitate) to Show Delayed Time to Relapse Compared to Daily Oral Schizophrenia Therapies. Jul 16, 2014 396
Supply of Pharmaceutical products. Jul 16, 2014 533
S&M Brands, Inc. Announces FDA Approval On Its Newly Redesigned Riverside Cigarette Brands. Jul 15, 2014 468
Israel,United States : TEVA PHARMACEUTICALS' NDA filing for Bronchospasm Inhaler Albuterol MDPI gets FDA approval. Jul 15, 2014 156
United States : GLENMARK gets final ANDA approval from US FDA for Fluocinonide Cream. Jul 15, 2014 107
Upcoming Conference Calls, FDA Approvals, NDA Updates, and Donations - Analyst Notes on The Medicines Company, Bio-Rad, Spectrum Pharmaceuticals, Insys Therapeutics and Hanger. Jul 14, 2014 1592
Medac Pharma, Inc. Secures FDA Approval of Rasuvo (methotrexate) injection for Rheumatoid Arthritis, Poly-Articular-Course Juvenile Idiopathic Arthritis and Psoriasis. Jul 14, 2014 2340
Janssen Pharmaceuticals Seeks Expanded Label for Once-Monthly INVEGA SUSTENNA (paliperidone palmitate) to Show Delayed Time to Relapse Compared to Daily Oral Schizophrenia Therapies. Jul 14, 2014 2586
new milestone on kids' heart drug; Daresbury pharma firm wins approval from Euro regulator. Jul 11, 2014 357
United States : PERRIGO receives approval for store brand equivalent to Advil congestion relief tablets. Jul 11, 2014 165
Actavis Confirms Generic Diclegis Patent Challenge. Jul 11, 2014 912
Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis. Jul 10, 2014 713
Par Pharmaceutical Begins Shipment of Fluphenazine Decanoate Injection, USP. Jul 9, 2014 350
Astellas Submits U.S. New Drug Application for Isavuconazole for the Treatment of Invasive Aspergillosis and Invasive Mucormycosis. Jul 9, 2014 617
United States : Innovative Research Tool Pinpoints Potential Therapies for Multiple Sclerosis. Jul 9, 2014 468
Mylan Launches Generic Micardis Tablets. Jul 8, 2014 346
Perrigo Announces FDA Final Approval For The Store Brand Equivalent To Advil Congestion Relief Tablets, 200 mg/10 mg. Jul 8, 2014 680
Protein Sciences Receives Approval from FDA for 2014/15 Formulation of Flublok Influenza Vaccine. Jul 8, 2014 672
Actavis Confirms Generic Ampyra Patent Challenge. Jul 8, 2014 908
CANNABIS APPROVED FOR MS PATIENTS IN IRELAND; Law change allows sufferers to use drug on prescription for first time. Jul 8, 2014 472
Agreements, NDA Submissions, FDA Approvals, Enrollment Updates, and Index Inclusions - Analyst Notes on Jazz Pharmaceuticals, Vertex, NPS, StemCells and Achillion. Jul 7, 2014 1591
Reaction Biology Receives NIH Grant Award For Epigenetic Database. Jul 7, 2014 433
Cell firm wants speedy approval for heart drug. Jul 4, 2014 582
Eisai Receives European Commission Approval of Indication Expansion for Anticancer Agent Halaven for Advanced Breast Cancer After Only One Prior Chemotherapy. Jul 4, 2014 1179
United States : FDA approves Beleodaq to treat rare, aggressive form of non-Hodgkin lymphoma. Jul 4, 2014 442
U.S. FDA Accepts NDA Filing for Boehringer Ingelheim's Investigational Nintedanib and Grants Priority Review Designation for the Treatment of Idiopathic Pulmonary Fibrosis. Jul 2, 2014 878
Halaven (eribulin) Receives European Commission Marketing Authorisation Approval (MAA) for Advanced Breast Cancer After Only One Prior Chemotherapy. Jul 2, 2014 2139
United States : FDA seeks permanent injunction against California pharmaceutical company. Jul 2, 2014 369
Bayer introduces first FDA-approved soft chew in canine osteoarthritis pain management. Jul 1, 2014 947
Want to live? You now have a right to try. Brief article Jul 1, 2014 296
Actavis Confirms Generic Zubsolv Patent Challenge. Jun 30, 2014 934
United States : FDA approves Afrezza to treat diabetes. Jun 30, 2014 458
The FDA Approval Process: Overview, Pros, Cons, and its Effect on Share Prices; Analyst Report by BrokerBank Securities, Inc. Jun 27, 2014 583
IGI Laboratories, Inc. Announces Joint Stipulation. Jun 26, 2014 577
New Patents, Clinical Trial Updates, New Agreements, and FDA Approvals - Analyst Notes on Agile Therapeutics, Vanda, Galena, Nanosphere and Rockwell. Jun 26, 2014 1559
Multiple Sclerosis -- KOL Insight and Consensus Outlook Modules. Jun 26, 2014 2832
Boehringer Ingelheim Announces Nintedanib Expanded Access Program (EAP) for Patients with Idiopathic Pulmonary Fibrosis. Jun 24, 2014 902
Settlements, Statements, FDA Submissions and Approvals - Analyst Notes on Valeant, Pfizer, Actavis, Allergan and Teva. Jun 20, 2014 1590
Pricing of Offering, FDA Approvals, Launches, and Technical Updates - Analyst Notes on Tenet, Lannett, Wright Medical Group, Anika Therapeutics and Accuray. Jun 19, 2014 1498
IGI Laboratories, Inc. Announces Fourth ANDA Submission In 2014. Jun 19, 2014 534
IGI Laboratories, Inc. Announces Sixteenth ANDA Submission. Jun 18, 2014 518
Century-old drug approved for sleeping sickness may help treat autism: Study. Jun 18, 2014 272
United States : BRECKENRIDGE PHARMA launches duloxetine delayed-release capsules. Jun 18, 2014 110
United States : FDA grants approval to LANNETT CO for Codeine Sulfate Tablets. Jun 18, 2014 177
United States : TEVA s expanded indication for Azilect gets approval from FDA. Jun 17, 2014 289
Avion Pharmaceuticals, LLC, Announces positive feedback from the FDA on two New Drug Applications. Jun 16, 2014 322
Germany : FDA approves Bayer s Gadavist (gadobutrol) Injection as the first magnetic resonance contrast agent for evaluation of breast cancer in the United States. Jun 13, 2014 436
United States : US FDA Advisory Committee recommends no cardiovascular outcomes trial for peripherally-acting mu-opioid receptor antagonist (PAMORA) class including MOVANTIK. Jun 13, 2014 409
United States : BRECKENRIDGE PHARMACEUTICAL launches Duloxetine Delayed-release Capsules. Jun 13, 2014 105
Consent Expiry Extensions, Collaborations, Grants, Conference Presentations, and FDA Approvals - Analyst Notes on Forest Laboratories, Intuitive Surgical, Horizon Pharma, Cubist and BDSI. Conference news Jun 12, 2014 1651
Expansions, New Leadership, Annual Award Winners, FDA Approvals, and Abstracts Presentations - Analyst Notes on AbbVie, Amgen, Regeneron Pharmaceuticals Inc, Valeant Pharmaceuticals and Lilly. Jun 12, 2014 1636
FDA approves Bayer's Gadavist (gadobutrol) Injection as the first magnetic resonance contrast agent for evaluation of breast cancer in the United States. Jun 12, 2014 1518
Breckenridge Announces Approval for Duloxetine Delayed-release Capsules. Jun 12, 2014 235
Ireland : ACTAVIS finalises agreement to settle patent issue. Jun 11, 2014 133
Israel,United States : FDA sanctions TEVA for AZILECT to deal with stages of PARKINSONS DISEASE. Jun 11, 2014 209
United States : ACELLA PHARMACEUTICALS receives FDA approval for hemophilia treatment tranexamic acid injection. Jun 11, 2014 204
Stock Option Programs, Proposed Refinancing, FDA Approvals, and Conference Presentations - Analyst Notes on Aegerion, DaVita, DexCom, Impax and Sanofi. Conference news Jun 11, 2014 1524
FDA Drug Approvals, Dividends, Fast Track Designation, Event Sponsorship, and Expansion of Role - Analyst Notes on Biogen Idec, UnitedHealth Group, GW Pharmaceuticals, Questcor and Cigna. Jun 11, 2014 1677
Mylan Launches Generic Actonel Tablets, 150 mg. Jun 11, 2014 341
Makindus Receives Orphan Designation For MI-100 For Stargardt's Disease. Jun 10, 2014 420
United States : BioDelivery Sciences International Inc`s New Drug Application receives approval from FDA. Jun 10, 2014 171
United States : GENERIC Celecoxib approved by FDA. Jun 10, 2014 283
Valeant Pharmaceuticals Announces FDA Approval Of Jublia for the Treatment of Onychomycosis. Jun 9, 2014 1263
Mylan Launches Generic Paraplatin Injection. Jun 9, 2014 422
Supplemental New Drug Application for IMBRUVICA Accepted by the U.S. FDA and Priority Review Granted. Jun 9, 2014 2390
Acella Pharmaceuticals, LLC, Announces Approval of Tranexamic Acid Injection. Jun 9, 2014 452
United States : FDA approves the first antihemophilic factor, Fc fusion protein for patients with Hemophilia A. Jun 7, 2014 300
United States : US FDA gives approval to Paragon BioTeck's phenylephrine hydrochloride ophthalmic solution. Jun 7, 2014 134
India : AUROBINDO receives USFDA approval to market psychiatric drug. Jun 6, 2014 229
United States : EC approves extension of INVEGA antipsychotic drug. Jun 6, 2014 121
India,United States : US FDA grants approval to AUROBINDO PHARMA for Divalproex production. Jun 4, 2014 152
Women's Groups Launch Campaign to 'Even the Score' on FDA-Approved Treatments for Women's Sexual Dysfunction, Provide Voice for the 1-in-10 Women who Experience HSDD. Jun 4, 2014 1034
New PET Probes: A new way to streamline the IND process for FDA approval. Jun 4, 2014 456
Paragon BioTeck announces FDA Approved Phenylephrine Hydrochloride Ophthalmic Solution Readily Available. Jun 4, 2014 670
CorePharma, LLC Announces the Launch of Dextroamphetamine Sulfate Tablets, USP. Jun 4, 2014 239
FDA Approvals, Digital Health Guidance, Conference Presentations, and Recognitions - Analyst Notes on Intercept Pharmaceuticals, Cigna, Baxter, Questcor and Mallinckrodt. Conference news Jun 3, 2014 1643
United States : GE Healthcare Announces FDA Approval to Supply Technetium 99m Generators. Jun 2, 2014 436
Omeros Receives FDA Approval of Omidria(TM) for Use in Cataract and Other Intraocular Lens Replacement Procedures. Jun 2, 2014 1512
IGI Laboratories, Inc. Announces Fifteenth ANDA Submission. Jun 2, 2014 507
Fiagon AG Secures A Patent License Agreement With GE Healthcare, And Fiagon AG Has Received Notice Of 510(k) Clearance From The FDA As Well As Chinese CFDA Approval. Jun 2, 2014 604
REDHILL BIOPHARMA AND INTELGENX COMMENCE STUDY. Jun 1, 2014 336
Drugs approved in 2013. Briggs, Gerald G. Jun 1, 2014 1467
Mylan Launches Generic Malarone Tablets. May 29, 2014 368
Nuvo Research[R] announces U.S. FDA approval of third-party generic of PENNSAID 1.5%. May 29, 2014 1863
Antiemetic Agent Aloxi Approved for Children by the U.S. FDA. May 29, 2014 488
FDA approves many drugs that up heart and stroke risk. May 28, 2014 185
Result of Annual Shareholders Meeting, Agreements, FDA Approval, Scheduled Conferences, and Dividends - Analyst Notes on Valeant Pharmaceuticals, Novartis, Teva, PTC Therapeutics and Agilent. Conference news May 28, 2014 1495
FDA Approves ALOXI (palonosetron HCl) to Prevent Nausea and Vomiting due to Chemotherapy in Children as Young as 1 Month. May 28, 2014 1657
United States : AZTHERAPIES gets FDA clearance to start Phase III trial of AD drug ALZT-OP1. May 28, 2014 213
Trimel Receives FDA Approval for Natesto(TM) Nasal Gel to Treat Men with Low Testosterone. May 28, 2014 1336
Actavis Confirms Generic Onglyza Patent Challenge. May 27, 2014 787
United States : FDA approves Dalvance to treat skin infections. May 24, 2014 395
Type 2 diabetes: European Commission approves Jardiance (empagliflozin) tablets for use in adults in Europe. May 23, 2014 1389
AZTherapies cleared to start enrolling under their IND for a Phase III clinical efficacy study for ALZT-OP1 in early Alzheimer's disease. Report May 23, 2014 1021
Novartis presents key advances in cancer research at ASCO and EHA from four new pivotal studies in lung, blood and skin cancers. May 22, 2014 6880
United States : FDA approves Entyvio to treat ulcerative colitis and Crohn's disease. May 21, 2014 421
FDA Approves Advantame as New Sweetener. May 21, 2014 442
Drugs that could help in fight against MERS-coronavirus revealed. May 20, 2014 269
Merck Animal Health Announces FDA Approval of BRAVECTO(TM) (fluralaner). May 20, 2014 1106
Company Updates, Takeover Offers, Stock Price Movements, and FDA Approvals - Analyst Notes on Chubb, Valeant, AstraZeneca, Mylan and Perrigo. May 20, 2014 1604
FDA Approves Takeda's Entyvio(TM) (vedolizumab) for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis or Crohn's Disease. May 20, 2014 2233
Scilex Pharmaceuticals Initiates Pivotal Pharmacokinetic Study for Ztilido(TM). May 19, 2014 961
New Sweetener Gains FDA Approval. May 19, 2014 510
Fight to save your life; Right to try experimental drugs. Wyatt, Kristen May 18, 2014 544
United States : ANDA receives final approval from FDA. May 16, 2014 127
Mylan Launches Generic Zyprexa Zydis Tablets. May 14, 2014 471
MannKind Corporation Pending FDA Approval Inspires Analyst Report by BrokerBank Securities, Inc. May 14, 2014 531
Supplemental New Drug Applications for Once-Monthly Long-Acting Therapy INVEGA SUSTENNA (paliperidone palmitate) Submitted to the U.S. FDA for the Treatment of Schizoaffective Disorder. May 13, 2014 3886
Supply of Pharmaceutical products. May 13, 2014 539
Supply of Pharmaceutical products. May 13, 2014 538
Providing of Pharmaceutical products. May 13, 2014 539
Actavis Receives Final Approval for Generic Version of Exalgo. May 13, 2014 669
FDA Approves Bayer's Kogenate FS Antihemophilic Factor VIII (recombinant) for Routine Prophylaxis in Adults with Hemophilia A. May 12, 2014 1523
Perrigo Company plc Announces FDA Approval Of Generic Version Of Astepro Nasal Spray. May 12, 2014 934
Positive Medicines Board Opinion, Stock Price Updates, Drug Approval, Dividend Announcement, and Settlement of Claims - Analyst Notes on Allergan, Amgen, Teva, Lilly and Medtronic. May 9, 2014 1533
United States : FDA approves Zontivity to reduce the risk of heart attacks and stroke in high-risk patients. May 9, 2014 403
United States : ACUR inks Settlement deal with RANBAXY. May 9, 2014 166
United States : FDA approves user of XOLAIR for treatment of chronic hives. May 9, 2014 156
CorePharma Launches Methylphenidate Hydrochloride Tablets USP. May 8, 2014 237
Drug access for cancer patients to be reviewed; Postcode lottery could be at an end. May 7, 2014 871
IGI Laboratories, Inc. Receives Tentative Approval Of Generic Equivalent For Diclofenac Sodium Topical Solution 1.5%. May 7, 2014 558
Robert Duggan Leading Innovation. May 7, 2014 702
United States : US FDA approves EPANOVA for the treatment of adults with severe hypertriglyceridaemia. May 7, 2014 437
Actavis Launches Generic Version of Catapres-TTS. May 7, 2014 631
The Jeffrey Epstein VI Foundation Backs Congress' Sunscreen Innovation Act To Fight Melanoma. May 6, 2014 500
TNI BioTech, Inc. Obtains Drug Approval For Sale of Low Dose Naltrexone (LDN) From Government of Malawi. May 6, 2014 1098
Solid Tumors Market in Asia Pacific to 2019 - New Drug Approvals and Anticipated Product Launches to Trigger a Shift in Treatment Paradigm to Targeted Therapies. May 6, 2014 2601
FDA Approves Ibalizumab Manufactured by WuXi PharmaTech for Treatment of Patients on Expanded Access. May 5, 2014 611
Assurex Health Releases Enhanced Pharmacogenomic Test to Help Clinicians Select Medications for Depression, Anxiety and PTSD. May 4, 2014 1735
Arteriocyte awarded FDA IDE approval to initiate clinical evaluation of MAGELLAN Bio-Bandage(TM) in Acute Deep Partial Thickness Thermal Injuries. May 2, 2014 656
United Kingdom : GSK receives approval for Incruse Ellipta (umeclidinium) in the US for the treatment of COPD. May 2, 2014 334
Cancer patients seven get life-saving drugs in times more likely to England than in Wales. May 1, 2014 1139
How English cancer drug fund opened up a divide with Wales. May 1, 2014 1348
Zykadia (ceritinib) approved for the treatment of late-stage lung cancer, Diplomat to distribute. May 1, 2014 593
FDA Approves Inspire Upper Airway Stimulation (UAS) Therapy for Obstructive Sleep Apnea. May 1, 2014 864
LUNGevity Foundation Applauds FDA Approval of Zykadia(TM) (ceritinib) as Additional Tool in Arsenal for Locally Advanced or Metastatic Non-Small Cell Lung Cancer. May 1, 2014 637
FDA approves image processing software from Halifax Biomedical. May 1, 2014 203
US FDA APPROVES ALPROLIX. May 1, 2014 852
Safety of infliximab in children with IBD: the experience of an academic center in WV. Northcutt, Michael; Subu, Awni Al-; Bella, Brooke; Elitsur, Yoram Report May 1, 2014 1983
FDA Approves New Liquid Form Of Treatment For Patients With Acute Lymphoblastic Leukemia (ALL) As Part Of A Combination Regimen. Apr 30, 2014 1064
GSK receives approval for Incruse(TM) Ellipta (umeclidinium) in the US for the treatment of COPD. Apr 30, 2014 1162
Switzerland : Novartis gains FDA approval for Zykadia(TM), first therapy for patients with ALK+ NSCLC previously treated with the ALK inhibitor crizotinib. Apr 30, 2014 444
United States : FDA approves Zykadia for late-stage lung cancer. Apr 30, 2014 440
United States : POZEN INC. secures complete response from FDA for PA8140/PA32540. Apr 28, 2014 328
Erdosteine Received Orphan Drug Status by the FDA. Apr 28, 2014 1006
Actavis Sues FDA Regarding Delay of Generic Celebrex Approval. Apr 28, 2014 822
Germany : Sorafenib Recommended for Approval in the European Union for the Treatment of Differentiated Thyroid Cancer. Apr 26, 2014 333
United States : SYLVANT (siltuximab) Receives FDA Approval to Treat Multicentric Castleman's Disease (MCD). Apr 25, 2014 455
United States : FDA approves Sylvant for rare Castleman s disease. Apr 25, 2014 332
Alimera Sciences Secures $35 Million Debt Facility. Apr 25, 2014 984
CrossBay Medical, Inc. announces FDA, Health Canada, and CE mark marketing authorizations for SonoSure SonoHysterography and Endometrial Sampling Device. Apr 25, 2014 525
TWi Announces Settlement of Lidoderm(R) Patent Litigation. Apr 23, 2014 404
SYLVANT(TM) (siltuximab) Receives FDA Approval to Treat Multicentric Castleman's Disease (MCD). Apr 23, 2014 2871
AbbVie Submits New Drug Application to U.S. FDA for its Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Hepatitis C. Apr 22, 2014 1051
AbbVie Submits New Drug Application to U.S. FDA for its Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Hepatitis C. Apr 22, 2014 1045
Marijuana Rated Significantly More Effective in Treating Fibromyalgia Symptoms than FDA-Approved Drugs, Global Survey Finds. Apr 21, 2014 586
Lilly's CYRAMZA(TM) (ramucirumab) Becomes First FDA-Approved Treatment for Advanced Gastric Cancer After Prior Chemotherapy. Apr 21, 2014 3862
Massive crack down against drug traffickers approved to make twin cities drug free. Apr 19, 2014 155
United Kingdom : GSK and Genmab receive FDA approval for ArzerraA (ofatumumab) as first-line treatment in combination with chlorambucil for patients with Chronic Lymphocytic Leukaemia (CLL) for whom f. Apr 18, 2014 313
United States : FDA approves Ragwitek for short ragweed pollen allergies. Apr 18, 2014 428
Volasertib, Boehringer Ingelheim's Investigational Oncology Compound, is Granted Orphan Drug Designation for Acute Myeloid Leukemia in the U.S. and EU. Apr 17, 2014 1145
The Zacks Analyst Blog Highlights:GIlead, AbbVie, MannKind, Alkermes and Pharmacyclics. Apr 17, 2014 2159
GSK and Genmab receive FDA approval for Arzerra (ofatumumab) as first-line treatment in combination with chlorambucil for patients with Chronic Lymphocytic Leukaemia (CLL) for whom fludarabine-based therapy is considered inappropriate. Apr 17, 2014 2743
Ruling says go to Zohydro; Patrick could ask maker to modify. Editorial Apr 17, 2014 145
Dr. Victor Lacombe is Excited to Announce That the FDA Approved New CoolSculpting Applicator for Outer Thigh Fat. Apr 16, 2014 157
Mylan Launches First Generic ORTHO EVRA Patch. Apr 16, 2014 463
Belgium : European Commission welcomes European Parliament's approval of new rules for pressure equipment. Apr 16, 2014 348
United States : FDA approves Tanzeum to treat type 2 diabetes. Apr 16, 2014 456
30-Year Ultra Long Gilt Futures Updates, Partnerships, Notes Offer Pricings, and Drug Approvals - Analyst Notes on IntercontinentalExchange, Western Union, Essex Property , Valeant and Pharmacyclics. Apr 15, 2014 1384
Mylan Launches Generic Lunesta Tablets. Company overview Apr 15, 2014 365
Zohydro ban stands for now; Federal judge hears more arguments from company, state. Marcelo, Philip Apr 15, 2014 366
Belgium : EUROPEAN COMMISSION approves of a joint procurement agreement. Apr 14, 2014 259
Depomed Announces Settlements with Two Gralise ANDA Filers. Apr 14, 2014 585
Healthcare Companies Report Product Availability, Earning Release Schedules, Event, and Stock Movements - Analyst Notes on Celgene, Vanda, Chelsea Therapeutics, Neurocrine Biosciences, and USANA. Apr 14, 2014 1445
Boehringer Ingelheim and Eli Lilly and Company Announce New Drug Application Filing in the U.S. for the Combination Tablet of Empagliflozin and Linagliptin. Apr 14, 2014 2059
ReCept Pharmacy to Distribute Otezla (apremilast): The First FDA Approved Oral Medication for the Treatment of Psoriatic Arthritis for Adults. Apr 14, 2014 425
Let's Get the Facts Straight About Zohydro(TM) ER--and the Important Patient Need It Fills. Apr 11, 2014 2581
FDA Approves Lipiodol (Ethiodized Oil) Injection for Imaging of Tumors in Adults with Known Hepatocellular Carcinoma (HCC). Apr 10, 2014 1281
The Zacks Analyst Blog Highlights:MannKind, Cubist, Medicines Co., Amgen and Halozyme. Apr 10, 2014 2111
Adverse reaction; Zohydro too dangerous in current form. Editorial Apr 10, 2014 424
United States : Supplemental New Drug Application for IMBRUVICA (ibrutinib) Submitted to the U.S. FDA. Apr 9, 2014 428
Waismann Method: Prescription painkiller/heroin overdose antidote approved by FDA. Apr 8, 2014 744
Updated with Multimedia Content: FDA Approves Pradaxa (dabigatran etexilate mesylate) for Treatment and Reduction in the Risk of Recurrence of Deep Venous Thrombosis and Pulmonary Embolism. Apr 8, 2014 3185
Zogenix Update on Legal Action. Apr 8, 2014 1028
Nexcyon Achieves European Regulatory Decision. Apr 7, 2014 648
FDA Approves Pradaxa (dabigatran etexilate mesylate) for Treatment and Reduction in the Risk of Recurrence of Deep Venous Thrombosis and Pulmonary Embolism. Apr 7, 2014 3114
Nexcyon Achieves European Regulatory Decision. Apr 7, 2014 451
Par Pharmaceutical Begins Shipment of Potassium Chloride Extended-Release Capsules. Apr 7, 2014 355
United States : FDA approves new hand-held auto-injector to reverse opioid overdose. Apr 4, 2014 452
United States : PACIRA PHARMA gets US FDA approval for an additional manufacturing suite for EXPAREL. Apr 4, 2014 150
Vt. is latest state to target powerful painkillers. Garbitelli, Beth Apr 4, 2014 537
U.S. Food and Drug Administration Approves Kaleo's EVZIO(TM) for the Emergency Treatment of Opioid Overdose. Apr 3, 2014 2134
United States : FDA approves first sublingual allergen extract for the treatment of certain grass pollen allergies. Apr 3, 2014 446
FDA APPROVES XOLAIR FOR PEOPLE WITH CIU. Apr 1, 2014 579
Janssen Submits New Drug Application to U.S. FDA for a Fixed-Dose Combination Tablet of HIV-1 Medicine Darunavir with Cobicistat as Part of Combination HIV Therapy. Apr 1, 2014 2061
Germany : Bayer s Adempas (riociguat) Approved for the Treatment of Two Life-Threatening Forms of Pulmonary Hypertension in the EU. Apr 1, 2014 440
Japan : Takeda Announces the New Drug Application Approval of Cell Cultured Influenza vaccine H5N1 "TAKEDA" 1mL and Cell Cultured Influenza vaccine (Prototype) "TAKEDA" 1mL in Japan for Prevention of. Apr 1, 2014 293
Judge won't block Arizona rules on abortion drugs. Schwartz, John Apr 1, 2014 461
Senator urges drug withdrawal. Anderson, Jane Apr 1, 2014 137
Momentum grows for GMO labeling: agreement on the best policy for informing consumers about products containing genetically modified organisms remains elusive. Sharaf, Maged Apr 1, 2014 1047
Senator wants FDA to pull Zohydro. Anderson, Jane Apr 1, 2014 294
United States : QUINTILES to support the launch of BIODELIVERY SCIENCES' Bunavail. Mar 31, 2014 209
United States : FDA approves first long-acting recombinant coagulation Factor IX concentrate for patients with Hemophilia B. Mar 29, 2014 307
Healthcare Companies Make Presentations, Submissions, Investigation Extensions, and Expansions - Analyst Notes on CR Bard, Medivation, Align Technology, Covance, and PAREXEL. Mar 28, 2014 1585
Investigation Report on China Pemetrexed Market, 2009-2018. Mar 28, 2014 715
Investigation Report on China Pemetrexed Market, 2009-2018. Mar 28, 2014 663
Taiwan Province of China,United States : TAIWAN cancer drug gets approval from FDA for clinical trials. Mar 28, 2014 172
Duchesnay USA Granted Kosher and Halal Certification for Diclegis (doxylamine succinate and pyridoxine hydrochloride), the Only FDA-Approved Treatment for Nausea and Vomiting of Pregnancy (NVP). Mar 27, 2014 1030
Drug Approvals, Stock Price Movements, and New Tools for Standardization - Analyst Notes on Biogen Idec, Alexion, Actavis, Thermo Fisher Scientific, and Medtronic. Mar 26, 2014 1451
Large Volume Injection Devices for Self-Administration. Mar 26, 2014 697
Large Volume Injection Devices for Self-Administration. Mar 26, 2014 691
Japan : Takeda Announces the New Drug Application Approval of TAKELDAA Combination Tablets, the Fixed Dose Combination of TAKEPRONA and Low-Dose Aspirin, in Japan. Mar 26, 2014 259
Japan : Takeda Announces the New Drug Application Approval of ZacrasA Combination Tablets LD and ZacrasA Combination Tablets HD in Japan for the Treatment of Hypertension. Mar 26, 2014 367
United States : US FDA grants approval to NOVARTIS for XOLAIR. Mar 26, 2014 126
United States : Drug Developers Drawn to Orphan Drugs Market: Financial Incentives Create Rich, Competitive Pipelines. Mar 26, 2014 388
Drug Developers Drawn to Orphan Drugs Market: Financial Incentives Create Rich, Competitive Pipelines. Mar 25, 2014 1137
Drug Developers Drawn to Orphan Drugs Market: Financial Incentives Create Rich, Competitive Pipelines. Mar 25, 2014 1135
New drug is lifeline for cancer sufferers. Mar 25, 2014 408
United States : BURMAN's launches new version of HEALTHTRAC. Mar 25, 2014 217
Actavis and Valeant Announce FDA Approval for Metronidazole 1.3%. Mar 25, 2014 1694
Actavis and Valeant Announce FDA Approval for Metronidazole 1.3%. Mar 25, 2014 1450
FDA approves oral drug for psoriatic arthritis. Mar 25, 2014 655
United States : FDA approves Otezla to treat psoriatic arthritis. Mar 22, 2014 373
FDA Approvals, Financial Highlights, Restated Treatment Indications, and Updates on Product Pipelines - Analyst Notes on Bristol-Myers Squibb, Galena, Teleflex, GW Pharmaceuticals, and CytRx. Mar 21, 2014 1678
Novartis Announces FDA Approval of Xolair (omalizumab) for Chronic Idiopathic Urticaria (CIU), a Form of Chronic Hives. Mar 21, 2014 2844
Healthcare Companies Report FDA Approvals, Comprehensive Analysis, Schedules, and Stock Movements - Analyst Notes on Pfizer, Johnson & Johnson, Biogen, Express Scripts, and Forest Laboratories. Mar 20, 2014 1493
FDA Approves Piramal Imaging's Neuraceq(TM) (florbetaben F18 injection) for PET Imaging of Beta-Amyloid Neuritic Plaques in the Brain. Mar 20, 2014 1333
Japan : Astellas and medivation submit supplemental new drug application for XTANDI (Enzalutamide) for chemotherapy-Naive advanced prostate cancer. Mar 20, 2014 216
United States : FDA approves Impavido to treat tropical disease leishmaniasis. Mar 20, 2014 403
Charity demands prostate cancer drug is approved. Mar 19, 2014 284
Ferring Pharmaceuticals Inc. Receives FDA Approval for the First and Only Mixed Protocol IVF Treatment -- Combines MENOPUR (menotropins for injection) and BRAVELLE (urofollitropin for injection, purified) in Single Syringe. Mar 19, 2014 1065
Children Dying While FDA Stalls on New Muscular Dystrophy Drug; Parents Seek 100,000 Signatures to Get White House's Attention. Mar 19, 2014 527

Terms of use | Copyright © 2014 Farlex, Inc. | Feedback | For webmasters